Physician profile
Michael R Willman
NPI 1033103916
$2,346.33
in general payments reported to CMS, 2019-2025
17 companies · $606 in 2025
The $606 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $133 · 2021: $125 · 2022: $223 · 2023: $466 · 2024: $350 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $524.58 | 2019-2025 | Clareon, Luxor, Centurion |
| Abbvie INC. | $455.79 | 2023-2025 | Durysta |
| Eyepoint US, INC. | $273.36 | 2019 | |
| Sight Sciences, INC. | $216.39 | 2019-2023 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $142.63 | 2023-2025 | Tecnis Iol |
| Eyevance Pharmaceuticals LLC | $125.36 | 2021 | |
| Bausch & Lomb Americas INC. | $112.11 | 2022-2024 | Xiidra, Miebo, Envista Aspire Toric |
| New World Medical,INC. | $106.61 | 2022-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Via360 |
| Sun Pharmaceutical Industries INC. | $89.70 | 2022-2025 | |
| Amgen INC. | $65.93 | 2024-2025 | Tepezza |
| Aerie Pharmaceuticals, INC. | $54.54 | 2019-2020 | |
| Ocular Therapeutix, INC. | $42.24 | 2019 | |
| Harrow Eye, LLC | $37.64 | 2025 | Vevye |
| Mallinckrodt Hospital Products INC. | $34.72 | 2024-2025 | Acthar |
| Akorn, INC. | $27.75 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $22.19 | 2025 | Photrexa Viscous and Photrexa |
| Mallinckrodt Enterprises LLC | $14.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Willman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.